查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1539366

動物分子診斷市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2033年

Veterinary Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球動物分子診斷市場的廣泛研究報告，對關鍵市場動態進行了全面分析，包括驅動因素、新興趨勢、機會和挑戰。本報告提供了對市場格局的全面了解，並幫助利害關係人做出明智的決策。

關鍵見解

  • 動物分子診斷市場規模（2024年）：2.147億美元
  • 市場預測金額（2033年）：4.377億美元
  • 全球市場成長率（2024-2033年年複合成長率）：8.2%

動物分子診斷市場 - 研究範圍：

動物分子診斷市場包含一系列用於準確檢測和分析動物疾病的先進診斷技術。這些技術包括聚合酶鏈反應（PCR）、次世代定序（NGS）和其他分子方法，為各種獸醫疾病的診斷提供高靈敏度和特異性。分子診斷對於識別寵物和牲畜的病原體、遺傳性疾病和其他健康問題非常重要，改善疾病管理和治療結果。該市場的推動因素包括分子生物學的進步、人畜共通疾病的日益普及以及對快速、準確的診斷解決方案不斷成長的需求。

推動市場成長的因素：

全球獸醫分子診斷市場受到幾個關鍵因素的推動，例如動物傳染病患者病率的上升、寵物飼養量的增加以及動物健康意識的提高。分子診斷可提供準確、及時的結果，對於有效的疾病管理和預防非常重要。診斷技術的進步，例如獸醫醫療基礎設施的擴大和攜帶式且易於使用的診斷設備的開發，也促進了市場的成長。此外，分子診斷與遠距醫療和數位健康解決方案的整合提高其可近性和採用率。

市場限制因素：

儘管成長前景廣闊，但動物分子診斷市場仍面臨挑戰，例如高成本以及對與先進診斷技術相關的專業知識的需求。將分子診斷引進獸醫實踐所需的初始投資可能很大，特別是對於規模較小的實踐。此外，人們也擔心分子診斷測試的標準化和監管，這可能會影響其採用和可靠性。應對這些挑戰需要不斷進步的技術、具有成本效益的解決方案和明確的監管框架，以確保分子診斷的廣泛接受和有效性。

市場機會：

由於技術創新和不斷變化的獸醫需求，獸醫分子診斷市場提供了巨大的成長機會。新型診斷分析和平台的市場發展，以及對個人化獸醫醫學日益成長的興趣，開闢新的市場擴張途徑。對疾病早期檢測和預防的需求不斷成長，加上寵物人性化的趨勢，預計將推動先進分子診斷的採用。策略合作夥伴關係、研發投資以及整合診斷解決方案的採用對於希望利用這些機會並推動市場成長的公司非常重要。

本報告中討論的關鍵問題

  • 推動動物分子診斷市場全球成長的關鍵因素是什麼？
  • 哪些應用和地區引領獸醫分子診斷的採用？
  • 技術進步如何重塑獸醫分子診斷市場的競爭格局？
  • 誰是動物分子診斷市場的主要參與者？ 他們採取什麼策略來保持競爭力？
  • 全球動物分子診斷市場的新趨勢和未來前景是什麼？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含/排除

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 市場創新/發展趨勢

第4章 關鍵成功因素

  • 主要促銷策略：依製造商分類
  • 主要法規
  • PESTEL 分析
  • 波特的分析
  • 產品發布活動
  • 產品採用/使用分析
  • 產品 USP/特點
  • 產量分析：依地區
  • 償付情境
  • 交易分析
  • 價值鏈分析

第5章 市場背景

  • 宏觀經濟因素
  • 預測因子 - 相關性和影響
  • 市場動態

第6章 COVID-19 危機分析

  • 新冠肺炎（COVID-19）與影響分析
    • 依產品
    • 依疾病分類
    • 依種類
    • 依最終用戶
    • 依國家/地區
  • 2024年市場情景

第7章 全球市場需求（金額或規模，百萬美元）分析

  • 2019-2023年過去的市值（百萬美元）分析
  • 2024-2033年當前和未來市場規模（百萬美元）的分析和預測：依市場分類
    • 年成長趨勢分析
    • 絕對數量機會分析

第8章 全球市場分析：依產品

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（百萬美元）分析：依產品
  • 2024-2033年當前和未來市場規模（百萬美元）分析和預測：依產品
    • PCR試劑盒
    • INAAT 套件
    • 微陣列晶片套件
    • DNA定序試劑盒
  • 市場吸引力分析：依產品分類

第9章 全球市場分析：依疾病分類

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（百萬美元）分析：依疾病
  • 2024-2033年當前和未來市場規模（百萬美元）分析和預測：依疾病
    • 無形體屬
    • 埃利希氏體屬
    • 新城疫
    • 流感
    • 豬繁殖與呼吸症候群（PRRS）
    • 其他
  • 市場吸引力分析：依疾病分類

第10章 世界市場分析：依類型

  • 簡介/主要發現
  • 歷史市場規模分析（百萬美元）：依類型，2019-2023年
  • 2024-2033年當前和未來市場規模（百萬美元）的分析和預測：依類型
    • 牲畜
    • 寵物
  • 市場吸引力分析：依類型

第11章 全球市場分析：依最終用戶

  • 簡介/主要發現
  • 2019-2023年歷史市場規模分析（百萬美元）：依最終用戶
  • 2024-2033年當前和未來市場規模（百萬美元）的分析和預測：依最終用戶
    • 動物醫院
    • 臨床實驗室
    • 獸醫研究所
  • 市場吸引力分析：依最終用戶分類

第12章 世界市場分析：依地區

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（百萬美元）分析：依地區
  • 目前與未來市場規模（百萬美元）分析預測：依地區，2024-2033年
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東、非洲
  • 市場吸引力分析：依地區

第13章 北美市場分析

第14章 拉丁美洲市場分析

第15章 歐洲市場分析

第16章 東亞市場分析

第17章 南亞市場分析

第18章 大洋洲市場分析

第19章 中東與非洲（MEA）市場分析

第20章 市場結構分析

  • 市場分析：依公司層級
  • 主要公司市佔率分析
  • 市場現況分析

第21章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭詳情
    • bioMerieux SA
    • IDEXX Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Qiagen NV
    • Neogen Corporation
    • ID. Vet
    • INDICAL BIOSCIENCE GmbH
    • Veterinary Molecular Diagnostics, Inc.

第22章 使用的先決條件與縮寫

第23章 研究方法

簡介目錄
Product Code: PMRREP12874

Persistence Market Research has recently published an extensive report on the global Veterinary Molecular Diagnostics market, providing a thorough analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report delivers a comprehensive understanding of the market landscape, helping stakeholders make informed decisions.

Key Insights:

  • Veterinary Molecular Diagnostics Market Size (2024E): USD 214.7 Mn
  • Projected Market Value (2033F): USD 437.7 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 8.2%

Veterinary Molecular Diagnostics Market - Report Scope:

The Veterinary Molecular Diagnostics market encompasses a range of advanced diagnostic technologies used for the precise detection and analysis of diseases in animals. These technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS), and other molecular methods that offer high sensitivity and specificity for diagnosing various veterinary conditions. Molecular diagnostics are crucial for identifying pathogens, genetic disorders, and other health issues in pets and livestock, leading to improved disease management and treatment outcomes. The market is driven by advancements in molecular biology, the increasing prevalence of zoonotic diseases, and the growing demand for rapid and accurate diagnostic solutions.

Market Growth Drivers:

The global Veterinary Molecular Diagnostics market is propelled by several key factors, including the rising incidence of infectious diseases in animals, increased pet ownership, and growing awareness about animal health. Molecular diagnostics offer precise and timely results, which are essential for effective disease management and prevention. The expansion of veterinary healthcare infrastructure and advancements in diagnostic technologies, such as the development of portable and user-friendly diagnostic devices, are also contributing to the market's growth. Additionally, the integration of molecular diagnostics with telemedicine and digital health solutions is enhancing their accessibility and adoption.

Market Restraints:

Despite its promising growth, the Veterinary Molecular Diagnostics market faces challenges such as high costs associated with advanced diagnostic technologies and the need for specialized expertise. The initial investment required for implementing molecular diagnostics in veterinary practices can be significant, especially for smaller clinics. Additionally, there are concerns related to the standardization and regulation of molecular diagnostic tests, which can impact their adoption and reliability. Addressing these challenges requires ongoing advancements in technology, cost-effective solutions, and clear regulatory frameworks to ensure the broad acceptance and effectiveness of molecular diagnostics in veterinary care.

Market Opportunities:

The Veterinary Molecular Diagnostics market presents significant growth opportunities driven by technological innovations and evolving veterinary needs. The development of novel diagnostic assays and platforms, along with the increasing focus on personalized veterinary care, is opening new avenues for market expansion. The rising demand for early disease detection and prevention, coupled with the growing trend of pet humanization, is expected to drive the adoption of advanced molecular diagnostics. Strategic partnerships, investments in R&D, and the introduction of integrated diagnostic solutions will be crucial for companies looking to capitalize on these opportunities and drive market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Veterinary Molecular Diagnostics market globally?
  • Which applications and regions are leading the adoption of Veterinary Molecular Diagnostics?
  • How are technological advancements reshaping the competitive landscape of the Veterinary Molecular Diagnostics market?
  • Who are the key players in the Veterinary Molecular Diagnostics market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Veterinary Molecular Diagnostics market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Veterinary Molecular Diagnostics market, such as IDEXX Laboratories, Neogen Corporation, and Zoetis, are focusing on innovation, technological advancements, and strategic collaborations to maintain a competitive edge. These companies are investing heavily in R&D to develop cutting-edge diagnostic solutions that improve animal health and streamline veterinary practices. Partnerships with research institutions, technology providers, and healthcare organizations are essential for expanding market reach and enhancing diagnostic capabilities. Emphasizing accuracy, cost-effectiveness, and comprehensive diagnostic solutions are key strategies for sustaining leadership in the rapidly evolving Veterinary Molecular Diagnostics market.

Key Companies Profiled:

  • bioMerieux SA
  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Neogen Corporation
  • ID. Vet
  • INDICAL BIOSCIENCE GmbH
  • Veterinary Molecular Diagnostics, Inc.

Key Segments Covered in Veterinary molecular diagnostics Industry Research

Product

  • PCR Kits
  • INAAT Kits
  • Microarray Kits
  • DNA Sequencing Kits

Disease

  • Anaplasma spp.
  • Ehrlichia spp.
  • New Castle Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome (PRRS)

Species

  • Livestock Animals
  • Companion Animals

End User

  • Veterinary Hospitals
  • Clinical Laboratories
  • Veterinary Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Promotional Strategies, by Manufacturers
  • 4.2. Key Regulations
  • 4.3. PESTEL Analysis
  • 4.4. Porter's Analysis
  • 4.5. Product Launch Activities
  • 4.6. Product Adoption/Usage Analysis
  • 4.7. Product USPs/ Features
  • 4.8. Production Analysis by Region
  • 4.9. Reimbursement Scenario
  • 4.10. Trade Analysis
  • 4.11. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Veterinary Diagnostics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Strategic Collaborations Among Key Players
    • 5.2.2. Rise in Awareness About Diseases in Animals Worldwide
    • 5.2.3. High Adoption of Molecular Diagnostic Kits for Veterinary Diseases
    • 5.2.4. Higher Prevalence of Chronic & Infectious Diseases in Animals
    • 5.2.5. Advancements in Molecular Technology
    • 5.2.6. Growing Acceptance of Advanced Molecular Diagnostic Techniques
    • 5.2.7. Ease in FDA Clearance for Veterinary Products
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Disease
    • 6.1.3. By Species
    • 6.1.4. By End User
    • 6.1.5. By Country
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2024-2033
    • 8.3.1. PCR Kits
      • 8.3.1.1. RT-PCR Kits
      • 8.3.1.2. RAPD-PCR Kits
    • 8.3.2. INAAT Kits
    • 8.3.3. Microarray Kits
    • 8.3.4. DNA Sequencing Kits
  • 8.4. Market Attractiveness Analysis by Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024-2033
    • 9.3.1. Anaplasma spp.
    • 9.3.2. Ehrlichia spp.
    • 9.3.3. New Castle Disease
    • 9.3.4. Influenza
    • 9.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
    • 9.3.6. Others
  • 9.4. Market Attractiveness Analysis by Disease

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Species

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis by Species, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Species, 2024-2033
    • 10.3.1. Livestock Animals
      • 10.3.1.1. Porcine
      • 10.3.1.2. Poultry
      • 10.3.1.3. Bovine/Cattle
      • 10.3.1.4. Aquatic
      • 10.3.1.5. Ovine
    • 10.3.2. Companion Animals
      • 10.3.2.1. Canine
      • 10.3.2.2. Feline
      • 10.3.2.3. Avian
  • 10.4. Market Attractiveness Analysis by Species

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
    • 11.3.1. Veterinary Hospitals
    • 11.3.2. Clinical Laboratories
    • 11.3.3. Veterinary Research Institutes
  • 11.4. Market Attractiveness Analysis by End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis Forecast by Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East & Africa
  • 12.4. Market Attractiveness Analysis by Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Disease
    • 13.3.4. By Species
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Disease
    • 13.4.4. By Species
    • 13.4.5. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Disease
        • 13.8.1.2.3. By Species
        • 13.8.1.2.4. By End User
    • 13.8.2. Canada Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Disease
        • 13.8.2.2.3. By Species
        • 13.8.2.2.4. By End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Product
    • 14.3.3. By Disease
    • 14.3.4. By Species
    • 14.3.5. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Disease
    • 14.4.4. By Species
    • 14.4.5. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Disease
        • 14.8.1.2.3. By Species
        • 14.8.1.2.4. By End User
    • 14.8.2. Brazil Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Disease
        • 14.8.2.2.3. By Species
        • 14.8.2.2.4. By End User
    • 14.8.3. Argentina Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Disease
        • 14.8.3.2.3. By Species
        • 14.8.3.2.4. By End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. Italy
      • 15.3.1.3. France
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Russia
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Disease
    • 15.3.4. By Species
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Disease
    • 15.4.4. By Species
    • 15.4.5. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Germany Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Disease
        • 15.8.1.2.3. By Species
        • 15.8.1.2.4. By End User
    • 15.8.2. Italy Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Disease
        • 15.8.2.2.3. By Species
        • 15.8.2.2.4. By End User
    • 15.8.3. France Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Disease
        • 15.8.3.2.3. By Species
        • 15.8.3.2.4. By End User
    • 15.8.4. U.K. Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Disease
        • 15.8.4.2.3. By Species
        • 15.8.4.2.4. By End User
    • 15.8.5. Spain Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By Disease
        • 15.8.5.2.3. By Species
        • 15.8.5.2.4. By End User
    • 15.8.6. BENELUX Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By Disease
        • 15.8.6.2.3. By Species
        • 15.8.6.2.4. By End User
    • 15.8.7. Russia Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By Disease
        • 15.8.7.2.3. By Species
        • 15.8.7.2.4. By End User

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product
    • 16.3.3. By Disease
    • 16.3.4. By Species
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Disease
    • 16.4.4. By Species
    • 16.4.5. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Disease
        • 16.8.1.2.3. By Species
        • 16.8.1.2.4. By End User
    • 16.8.2. Japan Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Disease
        • 16.8.2.2.3. By Species
        • 16.8.2.2.4. By End User
    • 16.8.3. South Korea Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Disease
        • 16.8.3.2.3. By Species
        • 16.8.3.2.4. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Thailand
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Disease
    • 17.3.4. By Species
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Disease
    • 17.4.4. By Species
    • 17.4.5. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Disease
        • 17.8.1.2.3. By Species
        • 17.8.1.2.4. By End User
    • 17.8.2. Indonesia Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Disease
        • 17.8.2.2.3. By Species
        • 17.8.2.2.4. By End User
    • 17.8.3. Malaysia Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Disease
        • 17.8.3.2.3. By Species
        • 17.8.3.2.4. By End User
    • 17.8.4. Thailand Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Disease
        • 17.8.4.2.3. By Species
        • 17.8.4.2.4. By End User

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Disease
    • 18.3.4. By Species
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Disease
    • 18.4.4. By Species
    • 18.4.5. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Disease
        • 18.8.1.2.3. By Species
        • 18.8.1.2.4. By End User
    • 18.8.2. New Zealand Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Disease
        • 18.8.2.2.3. By Species
        • 18.8.2.2.4. By End User

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. North Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Disease
    • 19.3.4. By Species
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Disease
    • 19.4.4. By Species
    • 19.4.5. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Disease
        • 19.8.1.2.3. By Species
        • 19.8.1.2.4. By End User
    • 19.8.2. Turkiye Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Disease
        • 19.8.2.2.3. By Species
        • 19.8.2.2.4. By End User
    • 19.8.3. South Africa Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Product
        • 19.8.3.2.2. By Disease
        • 19.8.3.2.3. By Species
        • 19.8.3.2.4. By End User
    • 19.8.4. North Africa Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Product
        • 19.8.4.2.2. By Disease
        • 19.8.4.2.3. By Species
        • 19.8.4.2.4. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. bioMerieux SA
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Sales Footprint
      • 21.3.1.4. Key Financials
      • 21.3.1.5. SWOT Analysis
      • 21.3.1.6. Key Developments
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. IDEXX Laboratories, Inc.
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Sales Footprint
      • 21.3.2.4. Key Financials
      • 21.3.2.5. SWOT Analysis
      • 21.3.2.6. Key Developments
      • 21.3.2.7. Strategy Overview
        • 21.3.2.7.1. Marketing Strategy
        • 21.3.2.7.2. Product Strategy
        • 21.3.2.7.3. Channel Strategy
    • 21.3.3. Thermo Fisher Scientific Inc.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Sales Footprint
      • 21.3.3.4. Key Financials
      • 21.3.3.5. SWOT Analysis
      • 21.3.3.6. Key Developments
      • 21.3.3.7. Strategy Overview
        • 21.3.3.7.1. Marketing Strategy
        • 21.3.3.7.2. Product Strategy
        • 21.3.3.7.3. Channel Strategy
    • 21.3.4. Qiagen N.V.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Sales Footprint
      • 21.3.4.4. Key Financials
      • 21.3.4.5. SWOT Analysis
      • 21.3.4.6. Key Developments
      • 21.3.4.7. Strategy Overview
        • 21.3.4.7.1. Marketing Strategy
        • 21.3.4.7.2. Product Strategy
        • 21.3.4.7.3. Channel Strategy
    • 21.3.5. Neogen Corporation
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Sales Footprint
      • 21.3.5.4. Key Financials
      • 21.3.5.5. SWOT Analysis
      • 21.3.5.6. Key Developments
      • 21.3.5.7. Strategy Overview
        • 21.3.5.7.1. Marketing Strategy
        • 21.3.5.7.2. Product Strategy
        • 21.3.5.7.3. Channel Strategy
    • 21.3.6. ID. Vet
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Sales Footprint
      • 21.3.6.4. Key Financials
      • 21.3.6.5. SWOT Analysis
      • 21.3.6.6. Key Developments
      • 21.3.6.7. Strategy Overview
        • 21.3.6.7.1. Marketing Strategy
        • 21.3.6.7.2. Product Strategy
        • 21.3.6.7.3. Channel Strategy
    • 21.3.7. INDICAL BIOSCIENCE GmbH
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Sales Footprint
      • 21.3.7.4. Key Financials
      • 21.3.7.5. SWOT Analysis
      • 21.3.7.6. Key Developments
      • 21.3.7.7. Strategy Overview
        • 21.3.7.7.1. Marketing Strategy
        • 21.3.7.7.2. Product Strategy
        • 21.3.7.7.3. Channel Strategy
    • 21.3.8. Veterinary Molecular Diagnostics, Inc.
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Sales Footprint
      • 21.3.8.4. Key Financials
      • 21.3.8.5. SWOT Analysis
      • 21.3.8.6. Key Developments
      • 21.3.8.7. Strategy Overview
        • 21.3.8.7.1. Marketing Strategy
        • 21.3.8.7.2. Product Strategy
        • 21.3.8.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology